The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus.

[1]  Heather M. Smith,et al.  Loss of HBsAg with interferon‐α therapy in chronic hepatitis D virus infection , 1993, Journal of medical virology.

[2]  J. Armstrong,et al.  The effect of combinations of ampligen and zidovudine or dideoxyinosine against human immunodeficiency viruses in vitro. , 1992, Antiviral research.

[3]  J. Hoofnagle,et al.  Long-term remission of chronic hepatitis B after alpha-interferon therapy. , 1991, Annals of internal medicine.

[4]  S. Bowden,et al.  Inhibition of Duck Hepatitis B Virus Replication in vivo by the Nucleoside Analogue Ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] Guanine) , 1991 .

[5]  C. Burrell,et al.  Serological analysis of duck hepatitis B virus infection. , 1990, Virus research.

[6]  I. Gust,et al.  Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compounds , 1990, Journal of medical virology.

[7]  S. Locarnini,et al.  Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model , 1990, Journal of medical virology.

[8]  B. Bloom,et al.  Alpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription , 1990, Journal of virology.

[9]  N. Jones,et al.  Reduced duck hepatitis B virus viraemia in ducklings coinfected with the immunodepressive reticuloendotheliosis virus , 1990, Journal of medical virology.

[10]  J. Summers,et al.  In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. , 1990, Virology.

[11]  J. Zeldis,et al.  Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patients , 1989, Journal of medical virology.

[12]  T. Shikata,et al.  Effect of 3′‐azido‐3′‐deoxythymidine on replication of duck hepatitis B virus in vivo and in vitro , 1989, Journal of medical virology.

[13]  S. Locarnini,et al.  INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDS , 1989, The Lancet.

[14]  K. Koike,et al.  Interferon inhibits hepatitis B virus replication in a stable expression system of transfected viral DNA , 1989, Journal of virology.

[15]  D. Montefiori,et al.  In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. , 1989, AIDS research and human retroviruses.

[16]  Y. Cossart,et al.  Virus-liver cell interactions in duck hepatitis B virus infection. A study of virus dissemination within the liver. , 1988, Gastroenterology.

[17]  M. Peters,et al.  Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial. , 1988, Annals of internal medicine.

[18]  A. Zuckerman.  Screening of antiviral drugs for hepadna virus infection in Pekin ducks: a review. , 1987, Journal of virological methods.

[19]  D. Montefiori,et al.  CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX , 1987, The Lancet.

[20]  D. Montefiori,et al.  Antiviral activity of mismatched double-stranded RNA against human immunodeficiency virus in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[21]  D. Montefiori,et al.  MISMATCHED DOUBLE-STRANDED RNA (AMPLIGEN) REDUCES CONCENTRATION OF ZIDOVUDINE (AZIDOTHYMIDINE) REQUIRED FOR IN-VITRO INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS , 1987, The Lancet.

[22]  J. Summers,et al.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.

[23]  Freiman Js,et al.  Natural duck hepatitis B virus infection in Australia. , 1986 .

[24]  M. Omata,et al.  Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks. , 1986, Gastroenterology.

[25]  J. Hoofnagle,et al.  Interferon in viral hepatitis: Role in pathogenesis and treatment , 1986, Hepatology.

[26]  T. Ikeda,et al.  Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life , 1986, Hepatology.

[27]  H. Thomas,et al.  Approaches to the Treatment of Hepatitis B Virus and Delta-Related Liver Disease , 1986, Seminars in liver disease.

[28]  D. Strayer,et al.  Comparative studies of ampligen (mismatched double-stranded RNA) and interferons. , 1985, Journal of biological response modifiers.

[29]  O. Yokosuka,et al.  Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA , 1985, Hepatology.

[30]  S. Schalm,et al.  ACYCLOVIR ENHANCES THE ANTIVIRAL EFFECT OF INTERFERON IN CHRONIC HEPATITIS B , 1985, The Lancet.

[31]  J. Hoofnagle,et al.  Treatment of chronic type B hepatitis with multiple ten‐day courses of adenine arabinoside monophosphate , 1985, Journal of medical virology.

[32]  R. Perrillo,et al.  Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B. , 1985, Gastroenterology.

[33]  Z. Varghese,et al.  Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. , 1983, The Journal of antimicrobial chemotherapy.

[34]  J. Summers,et al.  Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate , 1982, Cell.

[35]  Lu-Yu Hwang,et al.  HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS A Prospective Study of 22 707 Men in Taiwan , 1981, The Lancet.

[36]  P. I. Marcus,et al.  Defective interfering particles with covalently linked [±]RNA induce interferon , 1977, Nature.

[37]  W. Carter,et al.  An integrated and comparative study of the antiviral effects and other biological properties of the polyinosinic-polycytidylic acid duplex and its mismatched analogues. III. Chronic effects and immunological features. , 1976, Molecular pharmacology.

[38]  A. P. Norman,et al.  Letter: Skin wrinkling in cystic fibrosis. , 1974, Lancet.

[39]  P. Pitha,et al.  Structural requirements of the rI n -rC n complex for induction of human interferon. , 1972, Journal of molecular biology.

[40]  Evans Jw.  SPECIAL" CALLS IN GENERAL PRACTICE. , 1963 .

[41]  P. Staeheli.  Interferon-induced proteins and the antiviral state. , 1990, Advances in virus research.

[42]  O. Yokosuka,et al.  Effects of adenine arabinoside on serum and intrahepatic replicative forms of duck hepatitis B virus in chronic infection , 1987, Hepatology.

[43]  H. Levy,et al.  Utilization of Stabilized Forms of Polynucleotides , 1984 .

[44]  I. Cobden,et al.  初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .

[45]  W. Szmuness.  Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. , 1978, Progress in medical virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale.

[46]  E. Grunberg,et al.  Chemotherapeutic properties of coumermycin A1. , 1965, Antimicrobial agents and chemotherapy.